LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 62.29 | 84.90 | 1396 | 7934 | 0.1759 | 0.5338 | MN20160318_Q02 | F03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 62.29 | 84.90 | 1411 | 7934 | 0.1778 | 0.5363 | MN20160318_Q02 | F03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 62.29 | 84.90 | 1854 | 7934 | 0.2337 | 0.6017 | MN20160318_Q02 | I05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 62.29 | 84.90 | 1869 | 7934 | 0.2356 | 0.6037 | MN20160318_Q02 | I05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 63.99 | 84.90 | 1461 | 8212 | 0.1779 | 0.5394 | MN20160318_Q02 | F03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 63.99 | 84.90 | 1476 | 8212 | 0.1797 | 0.5418 | MN20160318_Q02 | F03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 63.99 | 84.90 | 1825 | 8212 | 0.2222 | 0.5922 | MN20160318_Q02 | I05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 63.99 | 84.90 | 1839 | 8212 | 0.2239 | 0.5941 | MN20160318_Q02 | I05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 65.70 | 84.90 | 1503 | 8484 | 0.1772 | 0.5413 | MN20160318_Q02 | F03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 65.70 | 84.90 | 1517 | 8484 | 0.1788 | 0.5434 | MN20160318_Q02 | F03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 65.70 | 84.90 | 1868 | 8484 | 0.2202 | 0.5926 | MN20160318_Q02 | I05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 65.70 | 84.90 | 1885 | 8484 | 0.2222 | 0.5947 | MN20160318_Q02 | I05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 67.41 | 84.90 | 1525 | 8766 | 0.1740 | 0.5399 | MN20160318_Q02 | F03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 67.41 | 84.90 | 1542 | 8766 | 0.1759 | 0.5425 | MN20160318_Q02 | F03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 67.41 | 84.90 | 1911 | 8766 | 0.2180 | 0.5927 | MN20160318_Q02 | I05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 67.41 | 84.90 | 1930 | 8766 | 0.2202 | 0.5951 | MN20160318_Q02 | I05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 69.11 | 84.90 | 1566 | 8988 | 0.1742 | 0.5424 | MN20160318_Q02 | F03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 69.11 | 84.90 | 1582 | 8988 | 0.1760 | 0.5448 | MN20160318_Q02 | F03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 69.11 | 84.90 | 1895 | 8988 | 0.2108 | 0.5868 | MN20160318_Q02 | I05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 69.11 | 84.90 | 1914 | 8988 | 0.2130 | 0.5891 | MN20160318_Q02 | I05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 70.81 | 84.90 | 1595 | 9132 | 0.1747 | 0.5444 | MN20160318_Q02 | F03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 70.81 | 84.90 | 1612 | 9132 | 0.1765 | 0.5468 | MN20160318_Q02 | F03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 70.81 | 84.90 | 1981 | 9132 | 0.2169 | 0.5948 | MN20160318_Q02 | I05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 70.81 | 84.90 | 1999 | 9132 | 0.2189 | 0.5969 | MN20160318_Q02 | I05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 72.52 | 84.90 | 1615 | 9214 | 0.1753 | 0.5459 | MN20160318_Q02 | F03 |